title: Hyperexpression of recombinant CFTR in heterologous cells alters its physiological properties.
abstract: We investigated whether high levels of expression of the cystic fibrosis transmembrane conductance regulator (CFTR) would alter the functional properties of newly synthesized recombinant proteins. COS-7, CFPAC-1, and A549 cells were intranuclearly injected with a Simian virus 40-driven pECE-CFTR plasmid and assayed for halide permeability using the 6-methoxy-N-(3-sulfopropyl)quinolinium fluorescent probe. With increasing numbers of microinjected pECE-CFTR copies, the baseline permeability to halide dose dependently increased, and the response to adenosine 3',5'-cyclic monophosphate (cAMP) stimulation decreased. In cells hyperexpressing CFTR, the high level of halide permeability was reduced when a cell metabolism poisoning cocktail was applied to decrease intracellular ATP and, inversely, was increased by orthovanadate. In CFPAC-1 cells investigated with the patch-clamp technique, CFTR hyperexpression led to a time-independent nonrectifying chloride current that was not sensitive to cAMP stimulation. CFPAC-1 cells hyperexpressing CFTR exhibited no outward rectifying chloride current nor inward rectifying potassium current either spontaneously or under cAMP stimulation. We conclude that hyperexpression of recombinant CFTR proteins modifies their properties inasmuch as 1) CFTR channels are permanently activated and not susceptible to cAMP regulation and 2) they lose their capacity to regulate heterologous ionic channels.
authors.affiliation: Laboratoire de Physiopathologie et de Pharmacologie Cellulaires et Moléculaires, Institut National de la Santé et de la Recherche Médicale CJF96-01, Hôpital Hotel-Dieu, Nantes, France.
authors.forename: R
authors.initials: R
authors.lastname: Mohammad-Panah
authors.forename: S
authors.initials: S
authors.lastname: Demolombe
authors.forename: D
authors.initials: D
authors.lastname: Riochet
authors.forename: V
authors.initials: V
authors.lastname: Leblais
authors.forename: G
authors.initials: G
authors.lastname: Loussouarn
authors.forename: H
authors.initials: H
authors.lastname: Pollard
authors.forename: I
authors.initials: I
authors.lastname: Baró
authors.forename: D
authors.initials: D
authors.lastname: Escande
mesh_terms: D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D019556:COS Cells; D000242:Cyclic AMP / Q000378:metabolism; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D017930:Genes, Reporter; D006801:Humans; D015640:Ion Channel Gating / Q000502:physiology; D008845:Microinjections; D018408:Patch-Clamp Techniques; D010957:Plasmids; D015221:Potassium Channels / Q000378:metabolism; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics; D013539:Simian virus 40; D014407:Tumor Cells, Cultured
chemical_list: D001565:Benzoates; C505032:CFTR protein, human; D015221:Potassium Channels; D011994:Recombinant Proteins; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C062963:diphenylcarboxylate; D000242:Cyclic AMP